MIG Fonds 18

MIG Fonds 18 is a direct venture capital fund, not a fund-of-funds. It invests directly in startups, primarily in high-tech sectors like biotech, medtech, and digital health. There's no intermediary layer of private equity funds underneath.

At the same time, it is marketed to retail investors. That’s unusual for VC, which is typically institutional territory. MIG has structured this as a German closed-end retail vehicle with features like capital calls, lock-up until 2037, and relatively low minimum investment thresholds (starting at €5,000 or €3,000 per capital call tranche). Of course, this comes with a different cost structure compared to traditional VC funds, which are primarily marketed to institutional investors (often with €1m minimum tickets or higher).